Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
10/28/2022* -- Results Q3 2022 -- 2.13 --
10/28/2022* 09:00 EST Earnings Call Q3 2022 -- -- --
07/28/2022 09:00 EST Earnings Call Q2 2022 -- -- --
07/28/2022 -- Results Q2 2022 2.47 2.21 11.93%
04/28/2022 -- Results Q1 2022 2.30 2.12 8.49%
04/28/2022 09:00 EST Earnings Call Q1 2022 -- -- --
02/17/2022 -- Results Q4 2021 2.04 1.92 6.53%
02/17/2022 09:00 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 10/28/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 07/28/2022
Beat/Miss Upgrade
Return Since -27.61%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.
URL https://www.westpharma.com
Investor Relations URL https://www.westpharma.com/Investors
HQ State/Province Pennsylvania
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Mid Cap/Growth
Next Earnings Release Oct. 28, 2022 (est.)
Last Earnings Release Jul. 28, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Apr. 19, 2022

Dividends

Dividend Per Share (TTM) 0.71
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.1964
Yield to Sector 0.1564
Yield to Industry 0.3296
Last Dividend Amt. 0.18
Dividend Frequency Quarterly
Last Ex-Dividend Date Apr. 19, 2022
Yield (TTM) 0.29%
Forward Yield 0.29%
Payout Ratio 7.64%
Cash Payout Ratio 13.05%
Consistent Payer (5Y) No
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
14.02%
41.88%
17.02%
-0.08%
54.14%
89.06%
65.88%
-47.48%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-23.87%
-0.84%
17.58%
47.29%
2.89%
28.39%
-2.94%
8.45%
-36.48%
15.71%
23.66%
55.41%
4.45%
46.25%
9.76%
-19.90%
-38.45%
-35.79%
-38.13%
-31.16%
-24.87%
108.1%
-27.93%
-13.82%
-40.72%
-7.59%
-78.57%
4.09%
-76.55%
-0.62%
-24.70%
-53.18%
28.54%
As of September 30, 2022.

Profile

Edit
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.
URL https://www.westpharma.com
Investor Relations URL https://www.westpharma.com/Investors
HQ State/Province Pennsylvania
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Mid Cap/Growth
Next Earnings Release Oct. 28, 2022 (est.)
Last Earnings Release Jul. 28, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Apr. 19, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
FSMEX 257.67M USD 3.39%
TRUZX 699.33M USD 3.04%
GDOC 2.786M USD 2.92%
CMGSX 470.74M USD 2.75%
BGRUX 151.18M USD 2.33%
NUMG 6.737M USD 2.22%
KONG 460024.0 USD 2.09%
NBGAX 189.52M USD 2.01%
FRDRX 465.74M USD 1.91%
NOBL 170.18M USD 1.65%
QGRO 3.602M USD 1.55%
NFJ 15.40M USD 1.17%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter WST Tweets